About 2 300 reports

Anal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Anal Cancer - Drugs In Development, 2022, provides an overview of the Anal Cancer (Oncology) pipeline landscape. Anal...

  • Cancer
  • China
  • Prescription Drug Sales
  • Medicine Use

The Cervical Cancer Therapeutics market is expected to grow at a CAGR of 4.14% during 2021-2027. Cervical cancer is a disease in which malignant cells are formed in the tissues of the cervix, the lower part of the uterus that connects to the vagina. Human papillomavirus (HPV) infection is the major risk factor for cervical cancer. According...

  • Cervical Cancer
  • China
  • Health Expenditure
  • Cervical Cancer Screening Coverage

Nasopharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Nasopharyngeal Cancer - Drugs In Development, 2022, provides an overview of the Nasopharyngeal Cancer (Oncology)...

  • Cancer
  • World
  • China
  • Prescription Drug Sales
  • Drug Approval

Rectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Rectal Cancer - Drugs In Development, 2022, provides an overview of the Rectal Cancer (Oncology) pipeline landscape. Rectal...

  • Cancer
  • World
  • United States
  • Prescription Drug Sales
  • Biosimilar Approvals

The global colorectal cancer market is expected to grow from US$ 18,619.3 million in 2022 to US$ 24,078.5 million by 2028; it is expected to grow at a CAGR of 3.3% from 2022 to 2028. Factors such as the increasing prevalence of colorectal cancer, product launches, and benefits offered by generic drugs are driving the growth of the global...

  • Colorectal Cancer
  • World
  • APAC
  • Medical Technology Density
  • Colorectal Cancer Screening Coverage

Hypopharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hypopharyngeal Cancer - Drugs In Development, 2022, provides an overview of the Hypopharyngeal Cancer (Oncology)...

  • Cancer
  • World
  • United States
  • Prescription Drug Sales

Cancer Pain (Central Nervous System) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cancer Pain - Drugs In Development, 2021, provides an overview of the Cancer Pain (Central Nervous System) pipeline landscape.Cancer pain can be defined as a...

  • Cancer
  • Drug Development
  • World
  • Drug Approval
  • Surgical Procedures Performed

Rectal Cancer (Oncology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Rectal Cancer - Drugs In Development, 2021, provides an overview of the Rectal Cancer (Oncology) pipeline landscape. Rectal cancer affects the lower part of the colon,...

  • Cancer
  • Drug Development
  • World
  • China
  • Drug Approval
  • Pharmaceutical Registrations

Cancer Anorexia-Cachexia Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cancer Anorexia-Cachexia Syndrome - Drugs In Development, 2022, provides an overview of the Cancer...

  • Cancer
  • World
  • Drug Approval
  • Energy Consumption

The gastrointestinal stent market is expected to reach USD 600 million by 2026 from USD 457 million in 2021, at a CAGR of 5.6 % during the forecast period of 2021 to 2026. Gastrointestinal (GI) stents are designed for palliative therapy for various diseases causing obstruction in the GI tract.GI stents have a major role in the recanalization...

  • Cancer
  • World
  • United States
  • North America
  • Europe
  • APAC
  • Health Expenditure
  • Cancer Incidence

The global prostate cancer nuclear medicine diagnostics market is expected to grow from US$ 720.12 million in 2022 to US$ 1,315.66 million by 2028. It is estimated to grow at a CAGR of 10.6% from 2022 to 2028. Prostate cancer affects the prostate glands in males.Prostate cancer is common cancer following skin cancer in males. Common...

  • Prostate Cancer
  • Diagnostics
  • World
  • Diagnostic Revenue
  • Health Expenditure

Muscle Invasive Bladder Cancer (MIBC) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) Clinical Trial Analysis by Trial Phase, Trial Status, Trial...

  • Bladder Cancer
  • Clinical Trial
  • World

Kidney Cancer Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change provides the strategists; marketers and senior management with the critical information they need to assess the global kidney cancer drugs market as it emerges from the COVID 19 shut down. Description: Where is the...

  • Renal Cancer
  • World
  • Health Expenditure
  • Public Health Expenditure

Human Papillomavirus (HPV) Associated Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Human Papillomavirus (HPV) Associated Cancer – Drugs In Development, 2022, provides an...

  • Cancer
  • Sexually Transmitted Disease
  • World
  • China
  • United Kingdom
  • Prescription Drug Sales
  • Stem Cell Transplantation

Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) pipeline Target constitutes close...

  • Cancer
  • Pharmaceutical
  • Therapy
  • Oncology
  • Drug Development
  • Ophthalmology
  • Eye Disease
  • Type 2 Diabetes
  • World

Vaginal Cancer - Global Clinical Trials Review, H2, 2021 Summary clinical trial report, “Vaginal Cancer - Global Clinical Trials Review, H2, 2021" provides an overview of Vaginal Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Vaginal Cancer....

  • Cancer
  • Clinical Trial
  • World

Brain Cancer - Epidemiology Forecast to 2030 Summary Primary brain cancer (ICD-10 = C70, C71, C72) is defined as a malignant neoplasm that originates in the central nervous system (CNS), which consists of the brain and spinal cord, including the brain stem (National Cancer Institute, 2021).The...

  • Brain Cancer
  • Epidemiology
  • China
  • Japan
  • United States
  • World
  • Cancer Incidence
  • Urban Population

Adrenocortical Carcinoma (Adrenal Cortex Cancer) (Oncology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Adrenocortical Carcinoma - Drugs In Development, 2021, provides an overview of the Adrenocortical Carcinoma (Oncology) pipeline landscape.Adrenal...

  • Cancer
  • Drug Development
  • World
  • Drug Approval
  • Cause-Specific Mortality Rate

Cancer Anorexia-Cachexia Syndrome (Oncology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cancer Anorexia-Cachexia Syndrome - Drugs In Development, 2021, provides an overview of the Cancer Anorexia-Cachexia Syndrome (Oncology) pipeline landscape. Cancer...

  • Cancer
  • Drug Development
  • World
  • Energy Consumption
  • Drug Approval

Gallbladder Cancer - Global Clinical Trials Review, H2, 2021 Summary clinical trial report, “Gallbladder Cancer - Global Clinical Trials Review, H2, 2021" provides an overview of Gallbladder Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on...

  • Cancer
  • Clinical Trial
  • World

Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, H2, 2021 Summary clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, H2, 2021" provides an overview of Muscle Invasive Bladder Cancer (MIBC) Clinical trials scenario. This report provides...

  • Bladder Cancer
  • Clinical Trial
  • World

China’s demand for Lung Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer...

  • Lung Cancer
  • China
  • Labour Force
  • Industrial Production

The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. By...

  • Healthcare
  • In Vitro Diagnostics
  • Pharmaceutical
  • Hospital
  • Breast Cancer
  • Biotechnology
  • Infectious Disease
  • Prostate Cancer
  • Neurodegenerative Disease
  • Cardiovascular Disease
  • Lung Cancer
  • World
  • North America
  • Europe
  • APAC
  • Cancer Incidence
  • Disposable Income

Gastric Cancer Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global gastric cancer drugs market as it emerges from the COVID 19 shut down. Description: Where is...

  • Gastric Cancer
  • World
  • Health Expenditure
  • Gross Domestic Product Per Capita

HER2-Positive Breast Cancer - Epidemiology Forecast to 2030 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide, accounting for 25.2% of all incident cases of female cancers, making the disease exceedingly prevalent. Breast cancer is classified...

  • Breast Cancer
  • Epidemiology
  • United States
  • United Kingdom
  • World
  • Cancer Incidence
  • Overweight Prevalence

Executive Summary Global Radiotherapy Market was valued at USD 7987.01 Million in the year 2020. Increasing healthcare expenditure on the back of growing disposable income, rapid technological advancements along with high prevalence of cancer is expected to drive the radiotherapy market significantly. Further, expanding...

  • Cancer
  • Specialty Hospital
  • World
  • Cancer Incidence
  • Health Expenditure

Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic...

  • Cancer
  • Pharmaceutical
  • Therapy
  • Oncology
  • World
  • Industrial Production

Head and Neck Squamous Cell Carcinoma - Epidemiology Forecast to 2030 Summary Head and neck cancers (HNCs) are a heterogeneous group consisting of cancers of the mouth, including the lip, tongue, gum, floor of mouth, palate, and other parts of mouth (ICD-10 code = C00-C06),; the salivary glands...

  • Cancer
  • Lung Cancer
  • Epidemiology
  • China
  • East Asia
  • Japan
  • United States
  • United Kingdom
  • World
  • France
  • Italy
  • Spain
  • Germany
  • Smoking Prevalence
  • Cancer Incidence

The global lung cancer surgery market is projected to reach USD 6.7 billion by 2026 from USD 5.4 billion in 2020, at a CAGR of 3.8% during the forecast period. Market growth is largely driven by factors such as the technological advancements in lung cancer treatment, increasing incidence and prevalence of lung cancer, growing trend of smoking...

  • Lung Cancer
  • World
  • United States
  • North America
  • Europe
  • Asia
  • Cancer Incidence
  • Health Expenditure

The global radiotherapy market is valued at USD 6.3 billion in 2022 and is expected to reach USD 8.1 billion by 2027, at a CAGR of 5.1% during the forecast period. Technological advancements in radiotherapy and the rising incidence of cancer are the major factors driving the growth of this market. Additionally, growing awareness of the benefits...

  • Cancer
  • Therapy
  • World
  • United States
  • North America
  • Europe
  • APAC
  • Cancer Incidence
  • Health Expenditure